| Authors: |
Ben-Ami E; NeuraLight LTD, Tel Aviv, Israel., Raveh E; NeuraLight LTD, Tel Aviv, Israel., Harpaz E; NeuraLight LTD, Tel Aviv, Israel., Riklin I; NeuraLight LTD, Tel Aviv, Israel., Band T; NeuraLight LTD, Tel Aviv, Israel., Gurevich T; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel., Alcalay RN; Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel.; Department of Neurology, Columbia University Irving Medical Center, New York City, USA., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Tosin MHS; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA., Goetz CG; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA., Rascol O; Department of Clinical Pharmacology and Neurosciences, Faculty of Medicine, University Hospital of Toulouse and INSERM, Clinical Investigation Center CIC 1436, NS-PARK/FCRIN Network, University of Toulouse, 37 Allées Jules Guesde, 31000, Toulouse, France. olivier.rascol@univ-tlse3.fr. |
